| Description |
Recombinant Human ADAM9 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Ala29-Asp697. |
| Purity |
> 95% as determined by Tris-Bis PAGE |
| Accession |
Q13443 |
| Target Symbol |
ADAM9 |
| Synonyms |
ADAM 9; Meltrin-gamma; Mdc9; Mltng; Adam9; Kiaa0021; AU020942; MDC9; mKIAA0021; CORD9; MCMP; MLTNG |
| Species |
Human |
| Expression System |
HEK293 |
| Tag |
C-His |
| Expression Range |
Ala29-Asp697 |
| Mol. Weight |
The protein has a predicted MW of 77.95 kDa. Due to furin cleavage site, the mature form migrates to 40-45 kDa and 60-70 kDa based on Tris-Bis PAGE result. |
| Form |
Liquid |
| Formulation |
Supplied as 0.22um filtered solution in 50mM Tris, 500mM NaCL, 0.005% Brij-35, 20% Glycerol (pH 8.5). |
| Endotoxin |
Less than 1EU per ug by the LAL method. |
| Storage |
Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
| Shipping |
Shipped with dry ice. |
| Gene Background |
A disintegrin and metalloproteinase 9 (ADAM9) is a member of the transmembrane ADAM family. It is expressed in different types of solid cancer and promotes tumor invasiveness. ADAM9 may be a prognostic marker for vestibular schwannomas (VS), and ADAM9 inhibition might have the potential as a systemic approach for the treatment of VS. |
